Succinylcholine Chloride
Product Images NDC 51662-1526

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Succinylcholine Chloride (NDC 51662-1526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Labeling (51662 1526 1 Serialized Vial Labeling)

A vial of Succinylcholine Chloride Injection, USP with a red cap. The label shows a strength of 200 mg/10 mL (20 mg/mL). It includes warnings stating it is a paralyzing agent requiring facilities for artificial respiration. The product is distributed by HF Acquisition Co., LLC in Mukilteo, WA, with a 10 mL multi-dose vial indicated.*

FDA Label Image

Box Warning (Box Warning)

A warning text panel discussing the risk of cardiac arrest from hyperkalemic rhabdomyolysis associated with succinylcholine chloride use. It details rare cases in pediatric patients, symptoms, recommended immediate treatments including intravenous calcium and glucose with insulin, and advises caution for use in emergency intubation or airway securing in children.*

FDA Label Image

How Supplied (How Supplied)

A data table presenting dosage details for SUCCINYLCHOLINE CHLORIDE. It lists a 10 mL Fliptrop Vial with concentration 20 mg/mL delivering a total of 200 mg, and a calculated osmolarity of 0.337 mOsmol/mL. Additional mention is made of multiple-dose vials with a related NDC number.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of succinylcholine chloride showing the organic molecule with quaternary ammonium groups and two chloride ions represented as Cl⁻.*

FDA Label Image

Vial (Vial Label)

Packaging label for Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL) by HF Acquisition Co LLC, DBA HealthFirst. The label includes a warning that it is a paralyzing agent for intravenous or intramuscular use, specifies that it is prescription only, and states it is a 10 mL multi-dose vial. The label measures approximately 70 mm by 25 mm and features a barcode and dosing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.